AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oncopeptides

Major Shareholding Notification Mar 11, 2021

3091_iss_2021-03-11_3fecc5df-87a2-4871-8f7c-b0811d634765.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Oncopeptides AB

Holder

Stiftelsen Industrifonden

Instrument

Instrument Ordinary shares
Before the transaction
Shares 0
Voting rights 0
Transaction
Reason for major shareholding notification Share loan
Date 10/03/2021
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction
Quantity
Shares 3,920,805
Directly held voting rights 3,920,805
Indirectly held voting rights 0
Percentage
Directly held shares 5.7587 %
Directly held voting rights 5.7587 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.7587 % 3,920,805
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
5.14065 % 3,500,000
- Physically settled
- Cash settled
Total 10.89935 % 7,420,805

Group total holdings

Voting rights 3,920,805 Percentage of voting rights 5.7587

Notes (other relevant informations according to law)

Flaggningen avser utlån av aktier i samband med nyemission i Oncopeptides. Flaggningen är baserad på 68 084 855 utestående aktier i Oncopeptides per 10 mars 2021, dagen då flaggningsskyldigheten uppstod.

Published

11/03/2021 14:02

Contact

Name Jonas Brambeck

Phone +46 70 879 19 37 Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.